After reinvigorating a decades-old schizophrenia drug in an innovative long-acting treatment option, Teva is looking to unlock its next chapter of mental health treatment. | The company’s latest innovation in the mental health realm is a long-acting version of olanzapine, an aging schizophrenia treatment that Eli Lilly markets as Zyprexa.